Bush, G., Fink, M., Petrides, G., Dowling, F. and Francis, A. (1996). Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica, 93, 129–136.
et al. (2010). A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Archives of General Psychiatry, 67, 793–802.
Kranaster, L., Kammerer-Ciernioch, J., Hoyer, C. and Sartorius, A. (2011). Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. European Archives of Psychiatry and Clinical Neuroscience, 261, 575–582.
Krystal, A. D.
et al. (2003). Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. The Journal of Neuropsychiatry and Clinical Neurosciences, 15, 27–34.
Krystal, A. D. and Coffey, C. E. (1997). Neuropsychiatric considerations in the use of electroconvulsive therapy. The Journal of Neuropsychiatry and Clinical Neurosciences, 9, 283–292.
Mathew, S. J.
et al. (2012). Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs, 26, 189–204.
Rao, V. and Lyketsos, C. G. (2000). The benefits and risks of ECT for patients with primary dementia who also suffer from depression. International Journal of Geriatric Psychiatry, 15, 729–735.
Rosow, C. and Manberg, P. J. (2001). Bispectral index monitoring. Anesthesiology Clinics of North America, 19, 947–966.
Sackeim, H. A.
et al. (1993). Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. The New England Journal of Medicine, 328, 839–846.
et al. (2011). Intensive care in psychiatry. European Psychiatry: the Journal of the Association of European Psychiatrists, 26, 260–264.
Zarate, C. A.
et al. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry, 63, 856–864.